Axelopran and Nivolumab in PD-1-Refractory Metastatic Melanoma
Clinical trial NCT07631325 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07631325
- Sponsor
- John Kirkwood
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-10-31
- Primary completion
- 2028-07-31
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.